MAT standards informed response to benzodiazepine harm reduction guidance
- Type
- Guidance
- Published
- 15 December 2023
- Drugs
Description
This guidance aims to set out key principles which align with the MAT standards and is designed for all staff supporting those who present with high risks of drug-related harms. This guidance encourages flexible and individualised high-intensity care, to support staff working in specialist treatment services who are regularly engaging with people using street benzodiazepines as well as opioids. Included is information on immediate changes you can make and action you can take to actively reduce harms by forming therapeutic relationships which consider the prescribing of benzodiazepines and the safe and effective delivery of appropriate psychosocial interventions.
Files
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.